Ajanta Pharma Limited

NSE:AJANTPHARM.NS

3198.5 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Assets:
Current Assets:
Cash & Cash Equivalents 1,307.73,298.32,063.61,775.12,023.5951.6906.4519.4549.61,367.7603.9462.3114.735147.605148.38680.68257.64974.51867.22528.147
Short Term Investments 3,300.55,138.21,218.62,006.7671.4647.41,848.31,815.6663.9194.6550000000000
Cash and Short Term Investments 4,608.28,436.53,282.23,781.82,694.91,5992,754.72,3351,213.51,562.31,153.9462.3114.735147.605148.38680.68257.64974.51867.22528.147
Net Receivables 12,80810,831.111,451.57,594.28,312.75,509.35,973.73,613.93,873.73,181.62,492.51,751.91,596.6720000000
Inventory 8,283.68,156.37,910.77,664.74,956.84,357.13,506.32,110.22,045.81,590.31,5541,4761,678.0121,131.2071,196.2471,038.921927.724708.358723.745674.569
Other Current Assets 1,609.4916.10.21,235.28,765.45,856.21.54074,379.5-0.10.1-0.17.291,545.7411,367.1231,489.9611,243.033975.249769.354621.496
Total Current Assets 27,309.228,34022,644.620,275.916,417.111,812.312,236.28,466.17,638.86,334.15,200.53,690.13,396.7092,824.5532,711.7562,609.5642,228.4061,758.1251,560.3241,324.212
Non-Current Assets:
Property, Plant & Equipment, Net 17,209.816,981.616,474.216,296.115,82914,331.811,065.49,211.96,8544,539.83,703.72,747.82,343.6632,312.4772,146.6311,934.4031,256.743754.384707.086695.867
Goodwill 00000000000000000000
Intangible Assets 146.677.590.2107.9117.166.574.571.959.843.125.7102.9142.720000000
Goodwill and Intangible Assets 146.677.590.2107.9117.166.574.571.959.843.125.7102.9142.7207.87600016.59713.374
Long Term Investments 279.4290294.239.5159.3130-1,772.5232.342.8205.8-465.484.60000000.080.08
Tax Assets 1,344.5967.7555.5501254318.1226.1244.5144.100-84.6000029.25785.53123.899135.426
Other Non-Current Assets 94.4133.4497.1566.8410.4303.12,656.20.474.8340.71,029641.4604.9784.64284.65284.65284.65284.722-0.001-0.002
Total Non-Current Assets 19,074.718,450.217,911.217,511.316,769.815,149.512,249.79,7617,175.55,129.44,2933,492.13,091.3532,397.1192,239.1592,019.0551,370.652924.636847.661844.745
Total Assets 46,383.946,790.240,555.837,787.233,186.926,961.824,485.918,227.114,814.311,463.59,493.57,182.26,488.0625,221.6724,950.9154,628.6193,599.0582,682.7612,407.9852,168.957
Liabilities & Equity:
Current Liabilities:
Account Payables 4,6324,227.73,271.73,738.63,623.42,251.82,496.31,395.71,455.71,090.61,245.41,317.100000000
Short Term Debt 117.694.364.6115.9622.53537.957.7780.6391.3781.8515.100000000
Tax Payables 447.7330.779.4489.2117037.280.4000000000000
Deferred Revenue 447.76,839.32,493.52,327.61,812.5-35337.2780.842.21,010.20000000000
Other Current Liabilities 3,760.3231.5644.1304.23.31,524.6919.1-0.1436.23.8727391.12,501.858917.85769.368549.739512.086363.631338.789221.291
Total Current Liabilities 8,957.611,392.86,473.96,486.36,061.73,776.43,460.52,234.12,714.72,495.92,754.22,223.32,501.858917.85769.368549.739512.086363.631338.789221.291
Non-Current Liabilities:
Long Term Debt 235.2262185.7197.7127.16.610.110.4148.7332.5523733.3760.8911,906.3032,279.6332,502.1451,735.4241,163.714983.659969.429
Deferred Revenue Non-Current -026.73033.436.70032.425.947.628.329.800000000
Deferred Tax Liabilities Non-Current 1,085977.21,018.7921.7811.6589470273.4199.8151.6229.9236.5170.909109.20952.695.6950000
Other Non-Current Liabilities 432.5251.6204.1191.8161.1137.7131.6-0.14.6252528.274.1070000000
Total Non-Current Liabilities 1,752.71,517.51,438.51,344.61,136.5733.3611.7316.1379556.7806.21,027.81,005.9072,015.5122,332.3232,507.841,735.4241,163.714983.659969.429
Total Liabilities 10,710.312,910.37,912.47,830.97,198.24,509.74,072.22,550.23,093.73,052.63,560.43,251.13,507.7652,933.3623,101.6913,057.5792,247.511,527.3451,322.4481,190.72
Equity:
Preferred Stock 000040,388.936,018.700000000000000
Common Stock 252.7252.7171.7173.9175.4175.4176.9176.9176.9176.8176.7118117.961117.961117.961117.961117.961117.961117.961117.961
Retained Earnings 33,143.431,412.727,17721,557.316,171.812,695.19,618.24,948.21,035.4997.7286.1304.700275.29200000
Accumulated Other Comprehensive Income/Loss 35,420.92,214.55,294.78,225.1-4,889.3-4,055.7-3,413.7-2,855.5-2,466.9-2,382.9-1,876.7-1,531.4-1,235.406-991.168-701.6-542.159-398.184-559.615-560.696-514.039
Other Total Stockholders Equity -33,143.4000-25,858.1-22,381.414,032.313,407.312,975.29,619.37,3475,039.84,097.7423,161.5172,157.5711,995.2381,628.7271,595.4661,525.3451,372.078
Total Shareholders Equity 35,673.633,879.932,643.429,956.325,988.722,452.120,413.715,676.911,720.68,410.95,933.13,931.12,980.2972,288.311,849.2241,571.041,348.5041,153.8121,082.61976
Total Equity 35,673.633,879.932,643.429,956.325,988.722,452.120,413.715,676.911,720.68,410.95,933.13,931.12,980.2972,288.311,849.2241,571.041,351.5481,155.4161,085.537978.237
Total Liabilities & Shareholders Equity 46,383.946,790.240,555.837,787.233,186.926,961.824,485.918,227.114,814.311,463.59,493.57,182.26,488.0625,221.6724,950.9154,628.6193,599.0582,682.7612,407.9852,168.957